
Blog
Precision Medicine Turns a Corner
by Zara Jethani
For many decades, cancers have been described—and even treated—according to the type of organ from which the cancer arises, such as lung, breast or brain. But increasingly doctors are looking at genetic information to determine how to best treat their patients and increase the chances...
PATIENT STORY: The Evolving Role of Caregivers
by Zara Jethani
Like many people, Alice Beirne was unprepared to become a cancer caregiver. But with hope and determination, Alice and a team of relatives stepped in to help a loved one navigate through a year of cancer treatment and recovery. “It’s a journey, and every day...
John Wayne Cancer Institute Welcomes New Faculty Members
by Zara Jethani
Pacific Neuroscience Institute (PNI) and the Saint John’s Cancer Institute (the Institute) have a very close relationship. PNI physician scientists conduct research and clinical trials in collaboration with the Institute’s scientists and the Pacific Neuroscience Research Center of Excellence is housed in the Institute building. These physicians...
Supporting a Cure for Brain Cancer
by Zara Jethani
A review of new research and treatments for brain cancer in 2016 TJ was diagnosed with a stage III Astrocytoma brain tumor at the age of 14. Even after four brain surgeries, several courses of radiation over 5 years, many kinds of chemotherapy, experimental treatments,...
Daniel F. Kelly, MD, Awarded 2016 Hospital Physician Leadership Award
by Guest Author
SANTA MONICA, CA – Daniel F. Kelly, M.D., professor of neuroscience and neurosurgery at the Saint John’s Cancer Institute and director of the Pacific Brain Tumor Center and Pituitary Disorders Center at Providence Saint John’s Health Center, was awarded the 2016 Hospital Physician Leadership Award...
Clinical Trials Round-Up: December 2016
by Zara Jethani
We have added a new clinical trial to our roster of brain tumor trials at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Orbus Therapeutics (NCT02796261): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine...
Seventh Annual Neuroscience Nursing Symposium at PNI
by Zara Jethani
The Annual Neuroscience Nursing Symposium is a one-day conference held in November each year that highlights new developments, evidence-based treatments, and neuroscience specialization in nursing practice. Amy Eisenberg, MSN, ARNP, CNRN, program director of the nursing symposium and nurse practitioner at Pacific Neuroscience Institute developed the...
PATIENT STORY: Clival Chordoma
by Amy Eisenberg
As I approach the Thanksgiving holiday, I am eternally grateful for Dr. Daniel Kelly, Dr. Garni Barkhoudarian, Dr. Chester Griffiths and their entire team. Because of these brilliant doctors and the staff at Saint Johns Health Center (now Providence), I am alive, healthy, strong and...
The Hidden Plight of Family Caregivers
by Marlon Saria
If this is the first time you are hearing that November is National Family Caregivers Month, you are not alone. Many Americans, including professional healthcare providers, are not aware that there is a month designated to promoting national recognition of family caregivers. President Clinton signed...
Clinical Trials Round-Up: November 2016
by Zara Jethani
We have recently added a new clinical trial protocol at the Pacific Neuroscience Research Center at PNI. NEW CLINICAL TRIAL Boehringer Ingelheim (NCT 02423525): A Phase I Dose Escalation and CNS Pharmacokinetic Study of the ErbB Family Inhibitor Afatinib in Patients with Recurrent or Progressive Brain...
Last updated: November 13th, 2019